Convalescent plasma therapy in an immunocompromised patient with multiple COVID‐19 flares: a case report
Abstract Convalescent plasma (CP) transfusion has been utilized as a salvage therapy in immunocompromised patients with severe COVID‐19 pneumonia. We describe the case of a 45‐year‐old immunocompromised patient, who received CP, in order to control multiple COVID‐19 flares and prolonged SARS‐CoV‐2 v...
Guardado en:
Autores principales: | Frini Karaolidou, Natasa‐Eleni Loutsidi, Zois Mellios, Edison Jahaj, Konstantinos Eleftheriou, Maria Pagoni, Ioannis Mpaltadakis, Athanasios‐Meletios Dimopoulos, Ioannis Kalomenidis, Apostolos G. Pappas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b919deb34fa14de5a674121036973794 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effectiveness of convalescent plasma therapy in eight non-intubated coronavirus disease 2019 patients in Indonesia: a case series
por: Theresia Monica Rahardjo, et al.
Publicado: (2021) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini M, et al.
Publicado: (2021) -
Convalescent plasma therapy in patients with coronavirus disease-19 – One year after: A brief review
por: Mariela Irabien-Zúñiga, et al.
Publicado: (2021) -
SEIR Mathematical Model of Convalescent Plasma Transfusion to Reduce COVID-19 Disease Transmission
por: Hennie Husniah, et al.
Publicado: (2021) -
Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors
por: Ravinder Singh, et al.
Publicado: (2021)